Skip to main content
Quest Diagnostics Home
Contact a representative
Call
Menu

Empowering you and your patients with the support you need, when you need it

Hormones are true biomarkers of health, and evidence continues to indicate the interrelationships between chronic cardiometabolic diseases. Create a personalized approach to reduce risk by testing your patients early to get them on a faster path to diagnosis, treatment, and management of their condition. If we can improve the gap in diagnosis rate for thyroid conditions, PCOS, and hypogonadism, we can uncover those at risk to identify and prevent cardiometabolic comorbidities. With 50 years of expertise in endocrine care, Quest makes it easy with 600+ medical experts on call, 225+ tests, and step-by-step guideline-based testing algorithms.

Quest is dedicated to supporting you with testing algorithms for common endocrine disorders

Thyroid testing algorithm
PCOS testing algorithm
Hypogonadism testing algorithm

Thyroid conditions 

- 20 million Americans are affected by a thyroid disorder, and up to 60% are unaware of their condition1

- Women are 5 to 8 times more likely to have a thyroid disorder, with 1 in 8 women estimated to develop a thyroid disorder during her life1

- Thyroid disorder symptoms vary according to the type of dysfunction and may initially be attributed to other causes

 

Choose the right test at the right time.

Download our thyroid testing algorithm Learn more about our thyroid offerings
Female doctor examining a female patient in his medical office while female nurse writing information about patient

Polycystic ovary syndrome (PCOS)

- 5-18% of women are affected by PCOS, with health impacts across their lifespan2-4

- 75% of individuals with PCOS remain undiagnosed due to variability in presentation and differences in published clinical diagnostic criteria5

- Approximately half of patients with PCOS will develop type 2 diabetes by age 405

 

Testing early means identifying risk factors faster.

Download our PCOS testing algorithm Learn more about our PCOS test offerings
Autoimmune diseases

Hypogonadism

-It is estimated that ~35% of men over age 45 have hypogonadism6

- 30%-50% of men with obesity or type 2 diabetes have hypogonadism7

- Fewer than 5% of affected patients receive treatment for hypogonadism8

 

Get the insights you need to diagnose and manage sooner.

Download our hypogonadism testing algorithm Learn more about our hypogonadism test offerings
Shot of a confident mature male doctor consulting a patient inside a hospital

Ready to connect with a Quest representative? 

Let's discuss your endocrine needs.

709

* indicates required

1. American Thyroid Association. General Information/Press Room. Accessed May 18, 2023. https://www.thyroid.org/media-main/press-room/

2. Joham AE, Norman RJ, Stener-Victorin E, et al. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 2022;10(9):668-680. doi:10.1016/S2213-8587(22)00163-2 

3. Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270-284. doi:10.1038/nrendo.2018.24

4. Azziz R. Polycystic ovary syndrome. Obstet Gynecol. 2018;132(2):321-336. doi:10.1097/AOG.0000000000002698

5. Centers for Disease Control and Prevention. PCOS (polycystic ovary syndrome) and diabetes. Reviewed March 24, 2020. Accessed August 18, 2022. https://www.cdc.gov/diabetes/basics/pcos.html

6.  Endocrine Society. Hypogonadism in men. January 24, 2022. Accessed February 8, 2024. https://www.endocrine.org/patient-engagement/ endocrine-library/hypogonadism

7. Endocrine Society. Hypogonadism in men. Published March 31, 2022. Accessed March 14, 2023 https://www.endocrine. org/patient-engagement/endocrine-library/hypogonadism. 

8. Mulligan T, Frick MF, Zuraw QC, et al. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60(7):762-769. doi:10.1111/j.1742-1241.2006.00992.x

9. Vigersky RA, Fish L, Hogan P, et al. The clinical endocrinology workforce: current status and future projections of supply and demand. J Clin Endocrinol Metab. 2014;99(9):3112-3121. doi:10.1210/jc.2014-2257. 

10. AACE Learning Center. Accessed August 3, 2023. https://learn.aace.com/Listing/SCOPE-Endocrinology-for-Primary-Care-5815

Our company

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.